
Home
Chapter Home
Jobs
Conferences
Fellowships
Books
Advertisement
Breast malignant, males, children
In situ carcinoma
Neuroendocrine DCIS
Reviewer: Dina Kandil, M.D. (see Reviewers
page)
Revised: 8 November 2012, last major update January 2012
Copyright: (c) 2001-2012, PathologyOutlines.com, Inc.
General
=========================================================================
● DCIS in which 50% or more cells express neuroendocrine markers
(Histopathology 2008;53:288)
● Regarded by some as DCIS with neuroendocrine features rather than a distinct type
Terminology
=========================================================================
● First described in 1985
(Histopathology 1985;9:21)
● Also called endocrine DCIS, intraductal or solid papillary carcinoma
(Am J Surg Pathol 1995;19:1237)
Epidemiology
=========================================================================
● 7% of DCIS cases
● Mean age 70 years, usually > age 60 years
(Zhonghua Bing Li Xue Za Zhi 2006;35:594)
Clinical
=========================================================================
● May have associated invasive component, either mucinous (colloid) or with neuroendocrine features
(Am J Surg Pathol 1996;20:921)
● Presents as breast mass or nipple discharge
(Am J Surg Pathol 1996;20:921)
● Associated with intraductal papilloma and pagetoid involvement by tumor cells
● Neuroendocrine markers are expressed in 67% of solid intraductal papillary carcinomas
(Virchows Arch 2007;450:539)
● Almost all DCIS with spindle cells have neuroendocrine differentiation
(Histopathology 2004;45:343)
Case reports
=========================================================================
● 68 year old woman with 1.5 cm breast nodule
(Am Surg 2000;66:1163)
● 72 year old woman with breast mass
(Case of the Week #45)
Micro description
=========================================================================
● Solid lobular growth, neuroendocrine-like festoons and rosettes and prominent fibrovascular septa
● Cells are polygonal, oval or spindled with abundant granular eosinophilic cytoplasm and bland ovoid nuclei
● Accumulation of basophilic intracellular mucin
● Often pagetoid spread and well developed vascular network
● Variable stromal sclerosis or signet ring cells
● Usually no necrosis
Micro images
=========================================================================
Case of the Week #45

Synaptophysin

Solid proliferation

Cribriform pattern

Small cells with dense, deeply stained amphophilic cytoplasm and uniform round nuclei

Focal Grimelius+ cells
Cytology description
=========================================================================
● Plasmacytoid tumor cells and arborizing papillary fronds
(Cancer 2000;90:286)
Cytology images
=========================================================================
Virtual slides
=========================================================================
Positive stains
=========================================================================
● Chromogranin, synaptophysin, neuron-specific enolase
● ER, PR
(Histopathology 2004;45:343)
● Low Ki-67
Negative stains
=========================================================================
● p53, HER2
EM description
=========================================================================
● Dense core neurosecretory granules, larger mucigen granules
Differential diagnosis
=========================================================================
● Florid epithelial hyperplasia and papilloma; lacks the monomorphic cell population associated with DCIS, negative for neuroendocrine markers
End of Breast malignant, males, children > In situ carcinoma > Neuroendocrine DCIS
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com
with any questions (click here for other
contact information).